title: [Recommendation of the working group commissioned by the French Nuclear Safety Authority on stereotactic radiation therapy].
abstract: OBJECTIVE
  At the request of the French nuclear safety authority (Autorité de Sûreté Nucléaire, ASN) a working party of multidisciplinary experts was initiated to elaborate a report regarding propositions for the clinical practice of stereotactic radiation therapy and the related medical physics.
  
  
  METHODS
  Several stereotactic radiation therapy experts were audited by the working party, especially neurosurgeons and neuroradiologists, as well as radiation oncologists, medical physicists and radiation technologists. An international survey was conducted looking at legal requirements and guidelines concerning stereotactic radiation therapy. A national survey was conducted in France among 29 departments performing stereotactic radiation therapy. The working party report was submitted for advice to the permanent group of medical experts of ASN.
  
  
  RESULTS
  Among the 13 countries who responded, very few have legal documents. Some of them are stating that stereotactic radiation therapy must be performed in a radiotherapy department and only by well-trained professionals. Guidelines describing the role of each participant have been published in the USA. In France, stereotactic radiation therapy is performed with dedicated machines or adapted linear accelerators. In 2009, within the 29 departments, 4247 patients were treated with stereotactic radiation therapy representing 4% of the patients treated with external beam radiation therapy. Intracranial lesions were: 3383 and extracranial: 864. The working party of multidisciplinary experts made 7 recommendations. The first one saying that stereotactic radiation therapy must be considered as a radiotherapy. The permanent group of medical experts is asking to modify the "décret du 19 mars 2007" regarding "radiosurgery".
  
  
  CONCLUSIONS
  The medical benefit of stereotactic radiation therapy is well admitted and it is an increasingly used technique. This work through practical guidelines and legal propositions intends to promote a well-controlled development of this radiotherapy technique.
authors.affiliation: Département de radiothérapie, centre Antoine-Lacassagne, 33 avenue de Valombrose, Nice cedex 2, France.
authors.forename: J-P
authors.initials: JP
authors.lastname: Gérard
authors.forename: B
authors.initials: B
authors.lastname: Aubert
authors.forename: I
authors.initials: I
authors.lastname: Buchheit
authors.forename: S
authors.initials: S
authors.lastname: Derreumaux
authors.forename: E
authors.initials: E
authors.lastname: Lartigau
authors.forename: I
authors.initials: I
authors.lastname: Latorzeff
authors.forename: A
authors.initials: A
authors.lastname: Lisbona
authors.forename: G
authors.initials: G
authors.lastname: Marinello
authors.forename: P
authors.initials: P
authors.lastname: Ménéchal
authors.forename: D
authors.initials: D
authors.lastname: Porcheron
authors.forename: N
authors.initials: N
authors.lastname: Zeghari Squalli
authors.forename: A
authors.initials: A
authors.lastname: Isambert
mesh_terms: D005602:France; D006801:Humans; D010315:Particle Accelerators; D011786:Quality Control; D016634:Radiosurgery / Q000592:standards*; D012449:Safety; D017751:Safety Management